In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Draxis Health Inc.

http://www.draxis.com

Latest From Draxis Health Inc.

Molecular Targeting Technology Inc.

Molecular Targeting Technology is developing radiopharmaceuticals for nuclear medicine and targeting agents for drug delivery. The company's lead product, {Amiscan} uses a small-molecule radiotracer to diagnose heart attack.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
    • Specialty Pharmaceuticals
UsernamePublicRestriction

Register